| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $54K | -97.9% |
| Cost of Revenue | $43K | -97.3% |
| Gross Profit | $11K | -98.9% |
| R&D Expense | $5.4M | -14.8% |
| SG&A Expense | $7.7M | +12.6% |
| Operating Income | -$13.2M | +55.4% |
| Interest Expense | $845K | +33.9% |
| Pre-tax Income | -$8.0M | +73.5% |
| Income Tax | $0 | — |
| Net Income | -$8.0M | +73.5% |
| EPS (Basic) | -$10.63 | -1280.5% |
| EPS (Diluted) | -$10.63 | -1280.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | -58.2% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $32K | -94.5% |
| Current Assets | $2.3M | -59.9% |
| Total Assets | $24.5M | -18.9% |
| Current Liabilities | $21.1M | -28.9% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.4M | +5.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $10.7M | -31.5% |
| Free Cash Flow | -$13.4M | +7.6% |
| $21.8M |
| -41.2% |
| Stockholders' Equity | $2.8M | +140.8% |